EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Rozy Thakur, Prateek Bhatia iD, Minu Singh iD, Sreejesh Sreedharanunni, Pankaj Sharma, Aditya Singh iD, Amita Trehan

Diagnostics · 25.02.2023 · 13 (5) · 884

DOI: 10.3390/diagnostics13050884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.02.2023. Verfasst von Rozy Thakur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology Oncology Unit, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, C…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methods

Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse) and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the non-relapse arm, were retrieved from the biobank for advanced genomic analysis. Deep sequencing (1050–5000X; mean 1600X) was performed using a custom NGS panel of 74 genes incorporating unique molecular barcodes.

Results

A total 47 major clones (>25% VAF) and 188 minor clones were noted in 40 cases after bioinformatic data filtering. Of the forty-seven major clones, eight (17%) were diagnosis-specific, seventeen (36%) were relapse-specific and 11 (23%) were shared. In the control arm, no pathogenic major clone was noted in any of the six samples. The most common clonal evolution pattern observed was therapy-acquired (TA), with 9/20 (45%), followed by M-M, with 5/20 (25%), m-M, with 4/20 (20%) and unclassified (UNC) 2/20 (10%). The TA clonal pattern was predominant in early relapses 7/12 (58%), with 71% (5/7) having major clonal mutations in the NT5C2 or PMS2 gene related to thiopurine-dose response. In addition, 60% (3/5) of these cases were preceded by an initial hit in the epigenetic regulator, KMT2D. Mutations in common relapse-enriched genes comprised 33% of the very early relapses, 50% of the early and 40% of the late relapses. Overall, 14/46 (30%) of the samples showed the hypermutation phenotype, of which the majority (50%) had a TA pattern of relapse.

Conclusions

Our study highlights the high frequency of early relapses driven by TA clones, demonstrating the need to identify their early rise during chemotherapy by digital PCR.

Schlagwörter

Stichwörter der Autor:innen

B-ALLdeep sequencingrelapsetherapy-acquired

Autor:innen und Institutionen

  • Pediatric Hematology Oncology Unit, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
  • Department of Haematology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
  • Department of Cardiovascular Medicine, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Prateek Bhatia, Minu Singh, Aditya Singh

Förderung

  • Science and Engineering Research Board
  • Indian Council of Medical Research

Zitieren

APA

Thakur, R., Bhatia, P., Singh, M., Sreedharanunni, S., Sharma, P., Singh, A., & Trehan, A. (2023). Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Diagnostics, 13(5), 884. https://doi.org/10.3390/diagnostics13050884

Vancouver

Thakur R, Bhatia P, Singh M, Sreedharanunni S, Sharma P, Singh A, et al. Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Diagnostics. 2023;13(5):884. doi:10.3390/diagnostics13050884

BibTeX
@article{Thakur2023,
  author = {Thakur, Rozy and Bhatia, Prateek and Singh, Minu and Sreedharanunni, Sreejesh and Sharma, Pankaj and Singh, Aditya and Trehan, Amita},
  title = {Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {5},
  pages = {884},
  doi = {10.3390/diagnostics13050884}
}
Kostenlos starten →